HOME >> MEDICINE >> NEWS
Doctors warn: Do not rely only on what young athletes say when managing concussions

PITTSBURGH, Sept. 11 When it comes to managing concussions in sports, relying only on an athlete's self report of symptoms is inadequate and likely to result in under-diagnosing the injury and the athlete unsafely returning to play following the concussion, warn doctors at the University of Pittsburgh Medical Center (UPMC) Sports Medicine Concussion Program. Along with assessing symptoms, the doctors stress, using computer-based neurocognitive function testing is crucial for accurate, objective evaluation of concussion and determining a safe return-to-play time for the athlete.

"Because of the tendency of some athletes to under-report their symptoms, presumably in an attempt to speed their return to the playing field, neurocognitive testing following suspected concussion is particularly important in keeping kids safe," said Mark Lovell, Ph.D., director of the UPMC Sports Medicine Concussion Program. Research has shown at least one in 10 high school or college athletes sustains a concussion each year.

Dr. Lovell's alert is based on a recent UPMC study of concussed high school and college athletes that showed unreliability of the athletes' self-reported symptoms and demonstrated the value of neurocognitive testing in significantly increasing the capacity to detect post-concussion abnormalities, decreasing the potential of exposure to additional injury. Previous research has shown that young concussed athletes who are returned to play too soon, before their brains have healed, are highly vulnerable to further injury, including post-concussion syndrome, or in rare cases, fatal second-impact syndrome. The current study is published in the upcoming issue of the American Journal of Sports Medicine, available online at www.ajsm.org.

"Given our study results, it is concerning that most return-to-play decisions following concussion have relied heavily on the athlete's self report of symptoms. In fact, in many s
'"/>

Contact: Susan Manko
MankoSM@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
11-Sep-2006


Page: 1 2 3 4

Related medicine news :

1. Doctors have key role in preventing and detecting child neglect and abuse
2. Doctors conclude temsirolimus is effective new treatment for advanced renal cell carcinoma
3. Doctors, engineers develop new wireless system to detect esophageal reflux
4. Doctors ill equipped to confront parent smoking
5. Doctors test effort that helps people understand health risk information
6. Doctors neglect insomnia in older patients
7. Doctors extended duration work shifts are associated with medical errors and adverse events
8. Doctors working overseas face having licenses removed
9. Doctors must debate hospital closures
10. Doctors cut repeat LASIK visits dramatically
11. Doctors know best when it comes to treating chronic coronary artery disease

Post Your Comments:
(Date:5/20/2013)... comprised over 24,000 Finnish subjects and was led ... a panel of 28 genetic markers improved detection ... disease (CHD) (10-year risk ≥20%) over traditional risk ... important preventive strategy for CHD, because the current ... "The results indicate that genetic markers could be ...
(Date:5/20/2013)... 32nd ESTRO European Cancer Congress will take place ... from Friday 17 September to Tuesday 1 October 2013. ... congress will build on the success of the previous ... Oncology) and ESTRO (European Society for Therapeutic Radiology and ... Europe to offer presentations of cutting-edge research across the ...
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 The producers ... segment dedicated to the essentials of home schooling. It will ... teachers will need to assist children in reaching educational goals. ... the most basic needs in education. Instructors can send tests ... connection to the Web. The celebrity-hosted segment is a top-notch ...
(Date:5/20/2013)... George Town, Grand Cayman, Cayman Islands (PRWEB) May ... City , a knowledge-based, high tech Special Economic ... launch of its Referral Network, an initiative to ... unique concessions combined with Cayman’s business-friendly environment and ... around the world, many of them referrals from ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Dr. Fanny J ... Brilliant, a gentle fractional laser treatment clinically proven to fight ... Clear + Brilliant are designed to prevent and ... + Brilliant can visibly illuminate skin tone, renew and smoothen ... skin, and reduce the appearance of pores. Developed by the ...
Breaking Medicine News(10 mins):Health News:Media registration for the European Cancer Congress 2Health News:Editions TV Presents a Home School Essentials Segment 2Health News:Cayman Enterprise City Introduces Referral Network 2Health News:Cayman Enterprise City Introduces Referral Network 3Health News:Delaware Dermatologist Now Offers Clear + Brilliant Gentle Laser Skin Rejuvenation Treatments 2
(Date:5/20/2013)... CLEVELAND , May 20, 2013 ... the healthcare industry by creating the Multi-Disciplinary Clinical ... a variety of medical experts with diverse healthcare ... the healthcare industry to create new software solutions ... the specific needs of patients and staff. ...
(Date:5/20/2013)... Enrollment of patients with Type 2 diabetes ... trial of product candidate NewMet ™, a delayed-release ... 2 diabetes. Elcelyx expects to complete enrollment of 240 ... of the trial,s primary endpoint of change in fasting ... read-out for long-term glucose lowering and weight benefits is ...
(Date:5/20/2013)... 2013  Rhythm announced today the presentation of results ... of gastroparesis symptoms among diabetic patients in the U.S. ... among patients with both type 1 and type 2 ... with the more common type 2 disease. ... Associate Professor of Medicine at Harvard Medical School and ...
Breaking Medicine Technology:Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4
Cached News: